Implementing thrombectomy for stroke treatment at a smaller hospital

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the implementation of mechanical thrombectomy for patients with large vessel occlusion stroke at Sørlandet Hospital, a limited-volume stroke center in Norway. The introduction of this treatment is guided by a simulation-based quality assurance program to address potential quality challenges. The study will monitor timelines, technical and clinical outcomes, and adverse events to assess the impact of this intervention on patient morbidity and mortality. By reducing transfer times to comprehensive centers, the study aims to improve patient outcomes in acute stroke care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patients
* Large vessel occlusion stroke

Exclusion Criteria:

* Intracranial hemorrhage, tumor, aneurism or vascular malformation i the stroke area
* More than 24 hours after stroke onset

Where it's running

• Sørlandet Hospital Health Trust
  Kristiansand, Agder, Norway Recruiting

Study contacts

• Principal investigator: Per Kristian Hyldmo, MD PhD — University of Stavanger, Norway
• Study coordinator: Olav Søvik, MD
• Email: olav.sovik@sshf.no
• Phone: +4741689421

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• NeuroAiD test in mild to moderate ischemic stroke patients

  This study tests whether adding MLC901 (NeuroAiD II) to standard stroke care helps adults who recently had an ischemic stroke recover better than standard care alone.

  Recruiting Phase 4 EVD Pharmacy and Medical Company Limited · Ho Chi Minh City · NCT07828210

• Intra-arterial Alteplase after successful reperfusion following mechanical thrombectomy

  This trial tests whether giving a small amount of alteplase directly into the artery after a successful thrombectomy helps adults with acute ischemic stroke recover better.

  Recruiting at 9 sites Phase 3 115 People's Hospital · An Giang and 12 other locations · NCT07727395

• Intra-arterial Thrombolysis After Endovascular Thrombectomy in AIS

  This trial tests whether giving intra-arterial thrombolysis with tenecteplase or alteplase after endovascular thrombectomy helps improve recovery in adults with acute ischemic stroke.

  Recruiting Phase 3 University of Calgary · Sydney, Barangaroo and 12 other locations · NCT07687056

• Early endovascular treatment for isolated internal carotid artery occlusion

  This trial tests whether giving early endovascular treatment, instead of best medical care alone, helps adults with acute ischemic stroke caused by an isolated internal carotid artery occlusion recover better.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang · NCT07016854

• IV tenecteplase given before clot removal for large-vessel ischemic stroke in the 4.5–24 hour window

  This trial tests whether a single IV dose of tenecteplase given before clot removal helps people with large-vessel ischemic stroke who arrive 4.5–24 hours after they were last well.

  Recruiting at 4 sites Phase 3 Xinqiao Hospital of Chongqing · Wuhan, Hubei and 3 other locations · NCT06987305

• Intra-arterial alteplase after successful reperfusion for anterior circulation ischemic stroke

  This trial tests whether giving intra-arterial alteplase after successful reperfusion improves 90-day functional outcomes for adults with anterior circulation large vessel occlusion stroke.

  Recruiting Phase 3 Central Hospital, Nancy, France · Nancy · NCT06768138

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.